Alltrna Revenue and Competitors
Estimated Revenue & Valuation
- Alltrna's estimated annual revenue is currently $12.9M per year.
- Alltrna's estimated revenue per employee is $155,000
Employee Data
- Alltrna has 83 Employees.
- Alltrna grew their employee count by 14% last year.
Alltrna's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CIO | Reveal Email/Phone |
2 | Chief IT Guy | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | VP, Medical and Regulatory Affairs | Reveal Email/Phone |
5 | SVP, Therapeutic Development and Pipeline Strategy at Alltrna | Reveal Email/Phone |
6 | VP, Discovery Platform | Reveal Email/Phone |
7 | VP People and Organization | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Senior Director, Oligonucleotide Chemical Development & Manufacturing | Reveal Email/Phone |
Alltrna Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Alltrna?
Alltrna is the first transfer RNA (tRNA) platform company, and our mission is to unlock tRNA biology and pioneer tRNA therapeutics to regulate the protein universe and resolve disease. Founded at Flagship Labs in 2018, Alltrna has mapped tRNA biology to systematically design tRNA medicines and encode a completely new, unifying approach to treating both rare and common human diseases driven by shared genetic mutations. Alltrna’s platform combines internal expertise and proprietary machine learning tools to unlock the entire tRNA biology space. We have an unprecedented opportunity to advance a single tRNA medicine to restore disrupted protein production, regardless of target, for thousands of diseases with the same underlying genetic mutation.
keywords:N/AN/A
Total Funding
83
Number of Employees
$12.9M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12M | 83 | -72% | N/A |
#2 | $7.5M | 83 | 2% | N/A |
#3 | $12.9M | 83 | -11% | N/A |
#4 | $12M | 83 | N/A | N/A |
#5 | $75M | 83 | 11% | $39.5M |